ACARD 300 mg, 300 mg, tabletki, Microcrystalline cellulose, Native corn starch, Citric acid anhydrous (E330) clinical trials

Long-term aspirin therapy as a predictor of decreased susceptibility to SARSCoV-2 infection in aspirin-exacerbated respiratory disease

This study looks at whether a special treatment for people with Aspirin-Exacerbated Respiratory Disease (AERD) can reduce their risk of getting COVID-19. They're testing if taking a particular type of aspirin long-term after initial desensitisation changes how certain genes work and makes you less likely to catch the virus.